Cyproheptadine Hydrochloride
NDC Package 50090-4724-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Cyproheptadine Hydrochloride is perennial and seasonal allergic rhinitis VasomotorrhinitisAllergic conjunctivitis due to inhalant allergens and foodsMild, uncomplicated allergic skin manifestations of urticaria and angioedema. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-4724 and is authorized under FDA application ANDA207555.

Identification & Billing

NDC Package Code
50090-4724-1
Package Description
30 TABLET in 1 BOTTLE
Product Code
50090-4724
11-Digit Billing Format
50090472401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cyproheptadine Hydrochloride
Dosage Form
-
Usage Information
Perennial and seasonal allergic rhinitis VasomotorrhinitisAllergic conjunctivitis due to inhalant allergens and foodsMild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasmaCold urticaria DermatographismAs therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
ANDA207555
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-01-2018
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-4724-1 identifies a specific commercial package of 30 tablet in 1 bottle of Cyproheptadine Hydrochloride, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on January 01, 2018. The current certification is valid through December 31, 2022.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090472401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-4724-1
11-Digit CMS (5-4-2)
50090-4724-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.